Join
Live feed
·
PRReleasevia Quantisnow
AC Immune SA logo
Takeda Pharmaceutical Company Limited logo

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACIU (AC Immune SA), TAK (Takeda Pharmaceutical Company Limited) and more on Quantisnow.